Beam Therapeutics (NasdaqGS:BEAM) Update / briefing Transcript

Beam Therapeutics (NasdaqGS:BEAM) Update / briefing March 25, 2026 08:00 AM ET Company ParticipantsAmy Simon - CMOAngela Qian - VP in Global Capital MarketsEddy Kim - Managing DirectorGiuseppe Ciaramella - PresidentHolly Manning - VP of Investor Relations and External CommunicationsJeff Teckman - Professor of Pediatrics, Biochemistry, and Molecular BiologyJohn Evans - CEOMatt Schainker - Executive Director in Global Healthcare GroupConference Call ParticipantsArabella Roden - Biotechnology Equity Research A ...